Fidelity Investments’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.84M | Buy |
792,010
+414,986
| +110% | +$5.57M | ﹤0.01% | 2052 |
|
|
2025
Q4 | $4.75M | Buy |
377,024
+83,453
| +28% | +$955K | ﹤0.01% | 2304 |
|
|
2025
Q3 | $2.94M | Buy |
293,571
+29,878
| +11% | +$268K | ﹤0.01% | 2402 |
|
|
2025
Q2 | $2.13M | Sell |
263,693
-40,312
| -13% | -$304K | ﹤0.01% | 2466 |
|
|
2025
Q1 | $2.55M | Buy |
304,005
+31,330
| +11% | +$262K | ﹤0.01% | 2367 |
|
|
2024
Q4 | $2.16M | Buy |
272,675
+69,165
| +34% | +$580K | ﹤0.01% | 2425 |
|
|
2024
Q3 | $1.69M | Buy |
203,510
+41,882
| +26% | +$328K | ﹤0.01% | 2445 |
|
|
2024
Q2 | $1.03M | Buy |
161,628
+12,201
| +8% | +$77.5K | ﹤0.01% | 2514 |
|
|
2024
Q1 | $906K | Sell |
149,427
-267
| -0.2% | -$1.51K | ﹤0.01% | 2535 |
|
|
2023
Q4 | $909K | Sell |
149,694
-5,918
| -4% | -$26.4K | ﹤0.01% | 2502 |
|
|
2023
Q3 | $657K | Buy |
155,612
+33,626
| +28% | +$125K | ﹤0.01% | 2560 |
|
|
2023
Q2 | $378K | Buy |
121,986
+555
| +0.5% | +$1.18K | ﹤0.01% | 2744 |
|
|
2023
Q1 | $169K | Sell |
121,431
-2,056
| -2% | -$4.09K | ﹤0.01% | 3045 |
|
|
2022
Q4 | $246K | Buy |
123,487
+658
| +0.5% | +$1.48K | ﹤0.01% | 2948 |
|
|
2022
Q3 | $248K | Sell |
122,829
-1,416
| -1% | -$3.97K | ﹤0.01% | 2993 |
|
|
2022
Q2 | $395K | Sell |
124,245
-8
| -0% | -$29 | ﹤0.01% | 2915 |
|
|
2022
Q1 | $518K | Buy |
+124,253
| New | +$550K | ﹤0.01% | 2979 |
|
|
2020
Q3 | – | Sell |
-77
| Closed | – | – | 3646 |
|
|
2020
Q2 | $0 | Sell |
77
-22
| -22% | -$91 | ﹤0.01% | 3553 |
|
|
2020
Q1 | $0 | Hold |
99
| – | – | ﹤0.01% | 3591 |
|
|
2019
Q4 | $0 | Hold |
99
| – | – | ﹤0.01% | 3753 |
|
|
2019
Q3 | $0 | Sell |
99
-10,056,869
| -100% | -$35.1M | ﹤0.01% | 3745 |
|
|
2019
Q2 | $72.1M | Buy |
10,056,968
+2,761,743
| +38% | +$28.2M | 0.01% | 1057 |
|
|
2019
Q1 | $103M | Sell |
7,295,225
-15,330
| -0.2% | -$203K | 0.01% | 892 |
|
|
2018
Q4 | $98.9M | Sell |
7,310,555
-2,728,554
| -27% | -$49.2M | 0.01% | 853 |
|
|
2018
Q3 | $223M | Buy |
10,039,109
+2,095,706
| +26% | +$44.1M | 0.03% | 630 |
|
|
2018
Q2 | $130M | Buy |
+7,943,403
| New | +$139M | 0.02% | 829 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
